Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Share News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
439.70    12.60 (2.95%)
Bid:
438.00
Ask:
438.10
Spread: 0.10 (0.023%)
Market Cap: £11.06b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Tuesday broker round-up

Tue, 07th Jan 2020 12:31
(Sharecast News) - SSE: Goldman Sachs downgrades to neutral with a target price of 1,461p.

Next: Berenberg reiterates hold with a target price of 6,140p.

Daily Mail and General Trust: Berenberg reiterates buy with a target price of 1,000p.

Bakkavor Group: HSBC downgrades to hold with a target price of 145p.

Big Yellow: Peel Hunt reiterates hold with a target price of 1,150p.

Derwent London: Peel Hunt reiterates hold with a target price of 3,850p.

Hammerson: Peel Hunt downgrades to hold with a target price of 300p.

Travis Perkins: Liberum Capital reiterates buy with a target price of 1,750p.

Smiths Group: Liberum reiterates hold with a target price of 1,840p.

Fevertree Drinks: Liberum reiterates buy with a target price of 2,780p.

BP: Barclays reiterates overweight with a target price of 650p.

NMC Health: Barclays reiterates overweight with a target price of 4,275p.

Safestore Holdings: Liberum downgrades to hold with a target price of 820p.

Britvic: Barclays reiterates equal weight with a target price of 940p.

Next: HSBC downgrades to hold with a target price of 7,050p.

BAE Systems: JP Morgan upgrades to overweight with a target price of 700p.

Standard Life Aberdeen: JP Morgan downgrades to neutral with a target price of 350p.

Marks & Spencer: Berenberg upgrades to buy with a target price of 250p.

Berkeley Group Holdings: Canaccord reiterates hold with a target price of 4,890p.

McCarthy Stone: Canaccord downgrades to sell with a target price of 134p.

Rentokil: Credit Suisse downgrades to neutral with a target price of 450p.

Related News

WINNERS & LOSERS: Segro leads FTSE 100, says ProLogis bid falls short
6 hours ago

WINNERS & LOSERS: Segro leads FTSE 100, says ProLogis bid falls short

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.

Homebuilder Berkeley calls for tax and regulatory rethink after 15% profit fall
6 hours ago

Homebuilder Berkeley calls for tax and regulatory rethink after 15% profit fall

* ​Chairman ⁠says London is delivering less than 10% ​of required homes

LONDON BROKER RATINGS: Berenberg says buy NatWest, hold Lloyds
7 hours ago

LONDON BROKER RATINGS: Berenberg says buy NatWest, hold Lloyds

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Rentokil Initial News

WINNERS & LOSERS: SDCL drops dividend; Rathbones pauses some inflows
16 Jun 2026

WINNERS & LOSERS: SDCL drops dividend; Rathbones pauses some inflows

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday.

IN BRIEF: Rentokil Initial names Carrasco as North America CEO
21 May 2026

IN BRIEF: Rentokil Initial names Carrasco as North America CEO

Rentokil Initial PLC - Crawley, England-based pest control services company - Appoints Rafael 'Rafa' Carrasco as chief executive officer, North Americ...

Rentokil Initial unveils new North America CEO
21 May 2026

Rentokil Initial unveils new North America CEO

(Sharecast News) - Rentokil Initial has named Rafael Carrasco as chief executive of its North American operations, it was confirmed on Thursday.

LONDON BROKER RATINGS: Goldman Sachs and Citi cut Sainsbury
27 Apr 2026

LONDON BROKER RATINGS: Goldman Sachs and Citi cut Sainsbury

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

LONDON BRIEFING: AstraZeneca wins US drug nod; GSK in court ruling
27 Apr 2026

LONDON BRIEFING: AstraZeneca wins US drug nod; GSK in court ruling

(Alliance News) - GSK reports on a US court ruling in ongoing litigation, AstraZeneca announces US approval for a self-administered lupus treatment, w...

WINNERS & LOSERS: Entain jumps; easyJet hit by higher fuel costs
16 Apr 2026

WINNERS & LOSERS: Entain jumps; easyJet hit by higher fuel costs

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday.